A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)

NCT00598208 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

325

Enrollment

INDUSTRY

Sponsor class

Conditions

Fertilization

Interventions

DRUG: corifollitropin alfa
DRUG: Follitropin beta injection

Sponsor

Organon and Co